Sedana Medical AB (SEDANA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sedana Medical AB (SEDANA) has a cash flow conversion efficiency ratio of -0.009x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-7.71 Million ≈ $-829.29K USD) by net assets (Skr888.45 Million ≈ $95.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Sedana Medical AB (SEDANA) market capitalisation for the company's overall valuation and market capitalisation.
Sedana Medical AB - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Sedana Medical AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Sedana Medical AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sedana Medical AB ranked by their cash flow conversion efficiency. Explore cash flow quality index of Sedana Medical AB to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chung Lien Transportation Co Ltd
TWO:5604
|
0.011x |
|
Net Insight AB (publ)
ST:NETI-B
|
0.068x |
|
China Silver Group Limited
F:2CS
|
0.015x |
|
Captor Therapeutics S.A.
WAR:CTX
|
-0.346x |
|
Purit Co. Ltd.
KQ:445180
|
0.022x |
|
Patriot National Bancorp Inc
NASDAQ:PNBK
|
-0.063x |
|
Bank of the James Financial Group
NASDAQ:BOTJ
|
0.024x |
|
Fast Food Indonesia Tbk
JK:FAST
|
0.583x |
Annual Cash Flow Conversion Efficiency for Sedana Medical AB (2016–2025)
The table below shows the annual cash flow conversion efficiency of Sedana Medical AB from 2016 to 2025. View Sedana Medical AB stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr900.78 Million ≈ $96.94 Million |
Skr-12.78 Million ≈ $-1.38 Million |
-0.014x | -15.51% |
| 2024-12-31 | Skr958.23 Million ≈ $103.12 Million |
Skr-11.77 Million ≈ $-1.27 Million |
-0.012x | +68.70% |
| 2023-12-31 | Skr970.00 Million ≈ $104.39 Million |
Skr-38.06 Million ≈ $-4.10 Million |
-0.039x | +65.02% |
| 2022-12-31 | Skr1.03 Billion ≈ $110.75 Million |
Skr-115.43 Million ≈ $-12.42 Million |
-0.112x | -199.71% |
| 2021-12-31 | Skr1.10 Billion ≈ $118.53 Million |
Skr-41.22 Million ≈ $-4.44 Million |
-0.037x | -162.86% |
| 2020-12-31 | Skr551.09 Million ≈ $59.31 Million |
Skr-7.85 Million ≈ $-844.35K |
-0.014x | +6.83% |
| 2019-12-31 | Skr569.38 Million ≈ $61.27 Million |
Skr-8.70 Million ≈ $-936.28K |
-0.015x | +42.41% |
| 2018-12-31 | Skr217.81 Million ≈ $23.44 Million |
Skr-5.78 Million ≈ $-621.90K |
-0.027x | -723.16% |
| 2017-12-31 | Skr116.40 Million ≈ $12.53 Million |
Skr495.60K ≈ $53.33K |
0.004x | -97.74% |
| 2016-12-31 | Skr1.26 Million ≈ $135.81K |
Skr238.00K ≈ $25.61K |
0.189x | -- |
About Sedana Medical AB
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a syringe with a connection to fit the c… Read more